Pursuant to Regulation 30 of SEBI LODR regulations this is to inform you that the United states Food and drug administration (USFDA) had inspected companys manufacturing facility located at Taloja. The inspection was conducted from 23rd September 2024 to 27th September 2024. On conclusion of the inspection the Company received 2 observations in Form 483. we are addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe.
हाल में देखा गया
सब क्लियर करें